Effects of intravenous laser blood irradiation at some indexes of the hemostatic system and disease activity degree (DAS28 index) in patients with rheumatoid arthritis
https://doi.org/10.37895/2071-8004-2019-23-1-23-26
Abstract
The aim of the present work was to study effects of intravenous laser blood irradiation (ILBI) at some indexes of plasma hemostasis and at the activity of rheumatoid arthritis.
Materials and methods. 130 people with confirmed rheumatoid arthritis were taken into the study. Patients in the control group (n = 30) received conventional medical therapy with basic anti-inflammatory drugs; patients in the main group (n = 100) had a course of intravenous laser therapy (ILBI) in addition to standard treatment. ILBI sessions were performed using laser device “Matrix-VLOK» (Matrix Ltd., Russia). Two laser heads were used for this therapy alternatively (every other day): KL-VLOK with wavelength 635 nm, output power at the end of the disposable fiber tip 1.5–2.0 mW, exposure 15 minutes and KL-VLOK 365 for UVBI with wavelength 365 nm, exposure 5 min. Daily sessions lasted for 10 days. Patients’ examination included analyses of activated partial thromboplastin time (APTT), prothrombin time (PTV), thrombin time (TV test), activity of protein C system as well as antithrombin III. Therapy dynamics and effectiveness were assessed with DAS28 index.
Results. It has been shown that ILBI sessions added to RA complex therapy significantly reduce disease activity and improve hemorheologic parameters.
About the Authors
N. N. BurduliRussian Federation
Vladikavkaz, North Ossetia-Alania Republic
L. A. Kulova
Russian Federation
Vladikavkaz, North Ossetia-Alania Republic
Z. S. Brсieva
Russian Federation
Vladikavkaz, North Ossetia-Alania Republic
References
1. Balabanova R.М., Erdes Sh.F. Prevalence of rheumatic diseases in Russia in 2012–2013 // Nauchno-practicherskaya revmatologia. 2015; 53 (2): 120–124.
2. Balabanova R.M., Erdes Sh.F. Dynamics of the prevalence of rheumatic diseases indicated in class XIII of ICD-10 in adult population in the Russian Federation in 2000–2010 // Nauchnopracticherskaya revmatologia. 2012; 52 (3): 10–12.
3. Galushko E.A., Erdes S.F., Bazorkina D.I. et al. Prevalence of rheumatoid arthritis in Russia // Terapevtichesky archive. 2010; 82 (5): 9–14.
4. Geynitz A.V., Moskvin S.V., Achilov A.A. Intravenous laser blood irradiation. M.: Tver, 2012: 336.
5. Gordeev A.V., Pozharov I.V. Anti-B-cell therapy – a new frontier in the treatment of rheumatoid arthritis // Kremlyovskaya medicina. Klinichesky vestnik. 2008; 1: 42–45.
6. Olyunin Yu.A. Determination of the activity of inflammatory process and evaluation of the effectiveness of systemic and local treatment of rheumatoid arthritis. Author. dis. doc. med. sciences. Moscow, 2007: 46.
7. Orlova E.V., Karateev D.E., Kochetkov A.V. et al. Rehabilitation therapy and rehabilitation of patients with rheumatoid arthritis: Current state of the problem. Part I – motor rehabilitation, orthotics, educational programs // Nauchno-practicherskaya revmatologia. 2011; 6: 78–89.
8. Bykerk V.P., Akhavan P., Hazlewood G.S. Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs. J. Rheumatol. 2012; 39 (8): 1559–1582.
Review
For citations:
Burduli N.N., Kulova L.A., Brсieva Z.S. Effects of intravenous laser blood irradiation at some indexes of the hemostatic system and disease activity degree (DAS28 index) in patients with rheumatoid arthritis. Laser Medicine. 2019;23(1):23-26. (In Russ.) https://doi.org/10.37895/2071-8004-2019-23-1-23-26